Increasing Hip and Knee Replacement Surgeries is Driving the Global Antithrombotic Drugs Market to Grow at 6.83% of CAGR by 2026

BOSTON, June 19, 2018 (Newswire.com) - Browse 23 market data Tables and 35 Figures spread through 216 Pages and in-depth analysis on “Global Antithrombotic Drugs market By Antithrombotic Drugs Types (Anticoagulants (Anticoagulants By Drugs Type, Anticoagulants By Rapid Onset Anticoagulant (Roa), Anticoagulants By Drug Class, Anticoagulants By Applications), Antiplatelets (Oral Antiplatelets, Iv Antiplatelets), Thrombin Inhibitors (Direct Factor Xa Inhibitors, Direct Thrombin Inhibitors, Thrombolytic Agents) Market by Geography- Regional Trends & Forecast to 2026.”

This insightful market research report from Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, and Rest of World, the report is a valuable asset for the existing players, new entrants, and the future investors. The study presents detailed market analysis with inputs derived from industry professionals across the value chain.

The Global Antithrombotic Drugs market was valued at nearly $24900 million in 2017 and is anticipated to reach $45100 million by 2026, growing at an estimated CAGR of 6.83%, during the forecast period 2018-2026.

Clive Cooper, Corporate Communications, Inkwood Research

Antithrombotic Drugs Market Scenario

Growing demand for NOACS, surge in hip and knee replacement surgeries, healthcare policies and programs by the government are the factors advancing the growth of the global Antithrombotic Drugs market.

The Antithrombotic Drugs Market report provides data tables, includes charts and graphs for visual analysis.

Request Free Sample Report for Global Antithrombotic Drugs Market by Antithrombotic drugs types & Geography. https://www.inkwoodresearch.com/reports/global-antithrombotic-drugs-market-forecast-2018-2026/#request-free-sample

Market Segmentation

On the basis of Antithrombotic drugs types, the Global Antithrombotic Drugs Market is segmented as follows:

·        ANTICOAGULANTS

·        ANTIPLATELETS

·        THROMBIN INHIBITORS

Report Highlights
- The report provides a detailed analysis of current and future market trends to identify the investment opportunities
- Market forecasts till 2026, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2026

Companies Profiled

-        ABBOT LABORATORIES

-        ARMETHEON INC.

-        BAXTER INTERNATIONAL

-        BAYER

-        BOEHRINGER INGELHEIM GMBH

-        BRISTOL-MYERS SQUIBB CO.

-        CSL BEHRING

-        DAIICHI SANKYO CO. LTD.

-        ELI LILLY AND COMPANY

-        HOFFMANN-LA ROCHE LTD

-        GLAXOSMITHKLINE

-        JOHNSON & JOHNSON

-        MERCK & CO

-        NOVARTIS

-        PFIZER

-        SANOFI

Related Reports

DIABETES DRUGS MARKET - Global diabetes drug market is expected to rise at a CAGR of 6.49% during the years 2018-2026.

IMMUNOHISTOCHEMISTRY MARKET - Global immunohistochemistry market is anticipated to grow at a CAGR of 7.93% during the years 2018-2026.

ATOPIC DERMATITIS DRUGS MARKET – Global Atopic Dermatitis Drugs market is anticipated to grow at a CAGR of 4.66% during the forecasting years 2018-2026.

Source: Inkwood Research